Abstract
The Aβ peptide has been identified as central to the onset and development of Alzheimers disease (AD) and several hypotheses about toxicity involving Aβ peptides have been proposed including mechanisms of oxidative stress and disruption of calcium homeostasis. The biology, structure and physical properties of Aβ peptides are discussed, as well as existing therapeutics and future strategies for the treatment of AD.
Keywords: amyloid, peptide, alzheimers disease, structure, therapeutic
Protein & Peptide Letters
Title: The Role of Aβ Peptides in Alzheimers Disease
Volume: 12 Issue: 6
Author(s): Anna K. Tickler, John D. Wade and Frances Separovic
Affiliation:
Keywords: amyloid, peptide, alzheimers disease, structure, therapeutic
Abstract: The Aβ peptide has been identified as central to the onset and development of Alzheimers disease (AD) and several hypotheses about toxicity involving Aβ peptides have been proposed including mechanisms of oxidative stress and disruption of calcium homeostasis. The biology, structure and physical properties of Aβ peptides are discussed, as well as existing therapeutics and future strategies for the treatment of AD.
Export Options
About this article
Cite this article as:
Tickler K. Anna, Wade D. John and Separovic Frances, The Role of Aβ Peptides in Alzheimers Disease, Protein & Peptide Letters 2005; 12 (6) . https://dx.doi.org/10.2174/0929866054395905
DOI https://dx.doi.org/10.2174/0929866054395905 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: Impact of Racial Differences on Brain Health among the Oldest Old
Current Alzheimer Research Memory and Consciousness in Alzheimers Disease
Current Alzheimer Research Tanshinone IIA: Pharmacology, Total Synthesis, and Progress in Structure-modifications
Current Medicinal Chemistry Peptide Sequence Prediction Supported by Correlation-Associated Networks in Human Cerebrospinal Fluid
Combinatorial Chemistry & High Throughput Screening Protein Nano-Fibrilar Structure and Associated Diseases
Current Proteomics EDITORIAL [Hot Topic: Diabetes Cardiovascular Complications (Guest Editor: Costanza Emanueli)]
Endocrine, Metabolic & Immune Disorders - Drug Targets Fad Diets: Dietary Dilemmas, Predicaments, and Recommendations for its Use
Current Nutrition & Food Science Past and Future Perspectives of Synthetic Peptide Libraries
Current Protein & Peptide Science The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Ginkgo Biloba Extract (EGb 761) in Alzheimers Disease: Is there Any Evidence?
Current Alzheimer Research MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study
Current Alzheimer Research Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience Use of Benzodiazepines and Haloperidol Among Orthopedic Patients in Postoperative Delirium. A Systematic Review
Current Psychopharmacology Clinical Applications of MAO-Inhibitors
Current Medicinal Chemistry Endophenotypes and Biological Markers of Schizophrenia: From Biological Signs of Illness to Novel Treatment Targets
Current Pharmaceutical Design Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Lead Finding for Acetyl Cholinesterase Inhibitors from Natural Origin: Structure Activity Relationship and Scope
Mini-Reviews in Medicinal Chemistry Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design Appraisal of AβPP Transgenic Mice as Models for Alzheimers Disease Amyloid Cascade
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents